SALT LAKE CITY–(BUSINESS WIRE)–Eyebot and The Framery at 1-800 Contacts today announced a new partnership kicking off in The Framery’s hometown of Salt Lake City, Utah. Beginning June 3, Eyebot Kiosks will be open at Layton Hills Mall in Layton, Utah…
Author: Business Wire
Phosio Raises $4 Million Seed Round to Bring Affordable AR/AI Glasses to Mass Market
CORVALLIS, Ore.–(BUSINESS WIRE)–Phosio raised $4M to advance lightweight AR glasses with integrated displays using its proprietary thin-film platform and advanced materials.
Ollin Biosciences Announces Upcoming Presentations of 20-week Data from Randomized Head-to-Head Study of OLN324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration at Clinical Trials at the Summit 2026
AUSTIN, Texas–(BUSINESS WIRE)–Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced that 20-week study completion data from its head-to-head Phase 1b JADE clinic…
TearSolutions Receives FDA Orphan Drug and Fast Track Designations for Lacripep® in Neurotrophic Keratitis and Initiates Phase 2 Clinical Trial with First Patients Dosed
CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–TearSolutions, Inc. (“TearSolutions”), a clinical-stage biotechnology company developing novel ophthalmic therapeutics, today announced receiving Food and Drug Administration (FDA) Orphan Drug (ODD) and Fast Track…
Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that Todd C. Brady, M…
Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of Blink Triple Care Preservative Free eye drops, …
Samsung Bioepis Launches OPUVIZ™ (Aflibercept) 40 mg/mL Vial Across Europe, to Treat Ophthalmic Conditions
INCHEON, Korea–(BUSINESS WIRE)– #Europe–Samsung Bioepis launches Opuviz (aflibercept) in Europe.
Aurion Biotech to Highlight Momentum Across Upcoming Eye Bank and Ophthalmology Meetings in June
SEATTLE & CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)– #AECOS2026–Aurion Biotech, Inc. (“Aurion Biotech”), a commercial-stage regenerative cell therapy company dedicated to restoring vision, today announced that the company will present at the Eye Bank…
Warby Parker Announces Participation in Upcoming 2026 Baird Global Consumer, Technology & Services Conference
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a lifestyle brand focused on vision for all, today announced that the Company will be presenting at the 2026 Baird Global Consumer, Technology & Services Conference on Tuesd…
Riassunto: ViaLase annuncia l'introduzione commerciale globale della procedura FLIGHT
ALISO VIEJO, Calif.–(BUSINESS WIRE)–ViaLase, Inc., un’azienda commerciale specializzata in tecnologia medica all’avanguardia nello sviluppo di soluzioni senza incisione, basate sul laser, per il trattamento del glaucoma, oggi ha annunciato di aver co…
ViaLase gibt weltweite Markteinführung des FLIGHT-Verfahrens bekannt
ALISO VIEJO, Kalifornien, USA–(BUSINESS WIRE)–ViaLase, Inc., ein kommerziell tätiges Medizintechnikunternehmen und Pionier im Bereich schnittfreier, laserbasierter Lösungen für die Behandlung von Glaukomen, gab heute den erfolgreichen Abschluss der e…
Samenvatting: ViaLase kondigt wereldwijde commerciële introductie van de FLIGHT-procedure aan
ALISO VIEJO, Calif.–(BUSINESS WIRE)–ViaLase, Inc., een medisch technologiebedrijf in de commerciële fase dat baanbrekend werk verricht met incisieloze, lasergebaseerde oplossingen voor glaucoom, heeft vandaag de succesvolle afronding aangekondigd van…
Resumen: ViaLase anuncia la implementación comercial del procedimiento FLIGHT a nivel mundial
ALISO VIEJO, California–(BUSINESS WIRE)–ViaLase, Inc., una empresa de tecnología médica en fase comercial pionera en soluciones láser sin incisión para tratar el glaucoma, ha anunciado hoy el éxito de los primeros procedimientos comerciales con FLIGH…
ViaLase annonce le lancement commercial mondial de la procédure FLIGHT
ALISO VIEJO, Californie–(BUSINESS WIRE)–ViaLase, Inc., une entreprise de technologie médicale en phase commerciale pionnière dans le domaine des solutions laser sans incision pour le traitement du glaucome, a annoncé aujourd’hui la réussite des premi…
GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs
SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today launched GoodRx Companion, a new $14.99-per-month subscription that brings together free and low-cost generic medications, af…
Ollin Biosciences to Participate in Upcoming Investor Conferences
AUSTIN, Texas–(BUSINESS WIRE)–Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced management will participate in two upcoming investor conferences: 2026 Jeffer…
Viridian Therapeutics to Participate in Upcoming June Investor Conferences
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today announced that memb…
Viridian Therapeutics to Participate in Upcoming June Investor Conferences
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today announced that memb…
FGX International Announces New Capsule Collection with Love Island
SMITHFIELD, R.I.–(BUSINESS WIRE)–FGX International, an EssilorLuxottica company and one of the world’s leading over-the-counter eyewear brands, has announced a new partnership with ITV Studios, home of one of the most-watched reality TV series worldw…
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure
ALISO VIEJO, Calif.–(BUSINESS WIRE)– #FLIGHTglaucoma–ViaLase announced the successful completion of the first commercial FLIGHT procedures, marking a new era in interventional glaucoma.